Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Independence day: Flipping from side-hustle to full-time requires grind behind glory
Founders found freedom in the journey (but they’re grateful for what they didn’t know was ahead) Jason Taylor walked away from big tech for good in January — leaving behind a dream résumé that included a long engineering career at Microsoft, then Google, for the freedom to pursue what had once been just a passion…
Family history, franchise model help second-chapter entrepreneur jump business obstacles
Throughout his career as a car salesman and mortgage broker, Brad Staples felt a calling toward entrepreneurship, he said. And when those industries ran dry, the Missouri native realized it was time to try on a familiar hat: running a family business. His venture, USA Ninja Challenge — a franchise kids’ fitness gym inspired by…
‘America the Entrepreneurial’: Can builders restore the promise of ‘the most courageous startup the world has ever seen?’
Risk-takers set the story of the United States of America in motion, said Victor W. Hwang, lamenting a modern day reality where needless barriers too often work against entrepreneurs and young businesses. An upcoming milestone birthday for the nation offers a focal point for restoring a coast-to-coast commitment to supporting builders and dreamers, he said,…
This Blue Valley teen uses AI to research cancer; Trump’s budget cuts could halt his work
Editor’s note: The following story was published by KCUR, Kansas City’s NPR member station, and a fellow member of the KC Media Collective. Click here to read the original story or here to sign up for KCUR’s email newsletter. An Overland Park high schooler traveled to Washington, D.C., to advocate for cancer research funding after the Trump administration proposed slashing…